These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 2502554

  • 21. Non-responsiveness of serum gonadotropins and testosterone to pulsatile GnRH in hemochromatosis suggesting a pituitary defect.
    Duranteau L, Chanson P, Blumberg-Tick J, Thomas G, Brailly S, Lubetzki J, Schaison G, Bouchard P.
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):351-4. PubMed ID: 8498154
    [Abstract] [Full Text] [Related]

  • 22. Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone's physiologic effects.
    Spratt DI, Finkelstein JS, O'Dea LS, Badger TM, Rao PN, Campbell JD, Crowley WF.
    Ann Intern Med; 1986 Dec; 105(6):848-55. PubMed ID: 3096182
    [Abstract] [Full Text] [Related]

  • 23. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
    Partsch CJ, Hermanussen M, Sippell WG.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
    [Abstract] [Full Text] [Related]

  • 24. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.
    Bagatell CJ, Dahl KD, Bremner WJ.
    J Androl; 1994 Jun; 15(1):15-21. PubMed ID: 8188534
    [Abstract] [Full Text] [Related]

  • 25. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF, Wang X, Zheng JJ, Liu ZX, Xu HL, Huang BK, Nie M, Wu XY.
    Asian J Androl; 2018 Jun; 20(4):319-323. PubMed ID: 29516878
    [Abstract] [Full Text] [Related]

  • 26. Circadian rhythm of plasma testosterone in men with idiopathic hypogonadotrophic hypogonadism before and during pulsatile administration of gonadotrophin-releasing hormone.
    Simoni M, Montanini V, Fustini MF, Del Rio G, Cioni K, Marrama P.
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):29-34. PubMed ID: 1559297
    [Abstract] [Full Text] [Related]

  • 27. Bioactive follicle-stimulating hormone responses to intravenous gonadotropin-releasing hormone in boys with idiopathic hypogonadotropic hypogonadism.
    Padmanabhan V, Kelch RP, Sonstein J, Foster CM, Beitins IZ.
    J Clin Endocrinol Metab; 1988 Oct; 67(4):793-800. PubMed ID: 3138278
    [Abstract] [Full Text] [Related]

  • 28. A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies.
    Ehrmann DA, Rosenfield RL, Cuttler L, Burstein S, Cara JF, Levitsky LL.
    J Clin Endocrinol Metab; 1989 Nov; 69(5):963-7. PubMed ID: 2529266
    [Abstract] [Full Text] [Related]

  • 29. Effect of gonadotropin-releasing hormone pulse frequency on gonadotropin secretion and subunit messenger ribonucleic acids in perifused pituitary cells.
    Ishizaka K, Kitahara S, Oshima H, Troen P, Attardi B, Winters SJ.
    Endocrinology; 1992 Mar; 130(3):1467-74. PubMed ID: 1537301
    [Abstract] [Full Text] [Related]

  • 30. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary.
    Sheckter CB, Matsumoto AM, Bremner WJ.
    J Clin Endocrinol Metab; 1989 Feb; 68(2):397-401. PubMed ID: 2493030
    [Abstract] [Full Text] [Related]

  • 31. Utility of free alpha-subunit as an alternative neuroendocrine marker of gonadotropin-releasing hormone (GnRH) stimulation of the gonadotroph in the human: evidence from normal and GnRH-deficient men.
    Whitcomb RW, O'Dea LS, Finkelstein JS, Heavern DM, Crowley WF.
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1654-61. PubMed ID: 1693373
    [Abstract] [Full Text] [Related]

  • 32. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C, Tso SC, Todd D.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [Abstract] [Full Text] [Related]

  • 33. Inhibin B secretion in males with gonadotropin-releasing hormone (GnRH) deficiency before and during long-term GnRH replacement: relationship to spontaneous puberty, testicular volume, and prior treatment--a clinical research center study.
    Nachtigall LB, Boepple PA, Seminara SB, Khoury RH, Sluss PM, Lecain AE, Crowley WF.
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3520-5. PubMed ID: 8855795
    [Abstract] [Full Text] [Related]

  • 34. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN, Wakefield G, Schlechter NL, Lindner J, Souza KH, Kamilaris TC, Konidaris S, Rivier JE, Vale WW, Toglia M.
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [Abstract] [Full Text] [Related]

  • 35. Pituitary luteinizing hormone responses to intravenous and subcutaneous administration of gonadotropin-releasing hormone in men.
    Spratt DI, Crowley WF, Butler JP, Hoffman AR, Conn PM, Badger TM.
    J Clin Endocrinol Metab; 1985 Nov; 61(5):890-5. PubMed ID: 3900124
    [Abstract] [Full Text] [Related]

  • 36. Pituitary and gonadal responses to the long-term pulsatile administration of gonadotrophin-releasing hormone in fetal sheep.
    Thomas GB, Brooks AN.
    J Endocrinol; 1997 Jun; 153(3):385-91. PubMed ID: 9203992
    [Abstract] [Full Text] [Related]

  • 37. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.
    Rochira V, Zirilli L, Genazzani AD, Balestrieri A, Aranda C, Fabre B, Antunez P, Diazzi C, Carani C, Maffei L.
    Eur J Endocrinol; 2006 Oct; 155(4):513-22. PubMed ID: 16990650
    [Abstract] [Full Text] [Related]

  • 38. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.
    Sykiotis GP, Hoang XH, Avbelj M, Hayes FJ, Thambundit A, Dwyer A, Au M, Plummer L, Crowley WF, Pitteloud N.
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3019-27. PubMed ID: 20382682
    [Abstract] [Full Text] [Related]

  • 39. Bio- and immunoactive luteinizing hormone responses to low doses of gonadotropin-releasing hormone (GnRH): dose-response curves in GnRH-deficient men.
    Spratt DI, Finkelstein JS, Badger TM, Butler JP, Crowley WF.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):143-50. PubMed ID: 3519645
    [Abstract] [Full Text] [Related]

  • 40. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
    Pavlou SN, Veldhuis JD, Lindner J, Souza KH, Urban RJ, Rivier JE, Vale WW, Stallard DJ.
    J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.